Revance Therapeutics Inc (RVNC) News

It's screwed up because you can't really factor in the shorts. The shorts feed off small bios and small caps when the markets are down or there is no news no updates no positives....the company could put out some kind of PR to calm every body down if the treatment(s) look like they will produce revenues and take market share. Just my take but the shorts can destroy a stock price.

It’s down because EV was hyped up and now people realize EV is not for everyone. R1s and R1j are not cheap, they cost about 70k usd after the recent car. These big ticket items are much more sensitive to financing rate and inflation.

Even Tesla is down 30 ytd

Nio xpev fisker lucid all down even more. So for rivn , its a sector thing

For RVNC, Eols is doing well, Botox sales was growing fine. So it’s not even a sector thing

Yes those who subscribed to the recent secondary already down like 50 percent

Doesn’t look good for Barlays at all

It’s odd. The purpose of the raise was to clear overhang. The stock drops half after the overhang is removed

Like how screw up is that

Why is RIVN down? Because their expenses have grown faster than their revenue. Because they're a newcomer in an industry with established brand heavyweights. Because the market is unsure if they can become profitable before they go bankrupt in a fearful interest rate environment. But if you've been following the story closely you know that their products are excellent—some of the best available—in a business with an increasing TAM. It sounds a lot like another stock we talk about frequently here, which might be why their YTD charts are nearly identical.

I know what u are saying actually but I just disagree that it’s a general market thing. The drop is very specific to RVNC, same for RIVN

As you all know, I am a long time injector of Daxxify since Prevu Dec 2022. I launched conservatively to a small portion of my practice, and since that time, Daxxify has taken over 80% of my own NT business (not including my nurse injectors). I used to be Botox only. This is the biggest revenue shift that I have seen in my practice in 20 years.

I am also seeing gradual adoption of Daxxify from many of my nurse injectors the past 3 quarters and we did over 6 figures of Daxxify purchases (over 400 vials) in Q1 2024. The march $75 rebates did help to get us to buy more Daxxify and to entice clients to try Daxxify. This represents over 500% growth over the Daxxify vials I used in Q12023. Although I am still the largest single injector of Daxxify in my organization, my nurse injectors, as a group, exceeded my total vials injected in Q4 2023 and have continued to grow their percentage of Daxxify used within my company.

Soma, thanks so much for your input. It is very encouraging to RVNC investors as they watch the stock price continue to sink. You should message Ms.Dtox before she sinks further into depression over RVNC as her big losses and tell her not to lose hope as it may yet turn into a gain.

I never said RVNC is down because of interest rates and inflation. Revance is down because they're a loss making company and they've grown expenses faster than revenues. The market has turned extremely negative on companies like that and punished them unduly on days where rates have moved higher. RVNC is essentially priced for bankruptcy at this point, as is RIVN, and many other companies, some of whom will go bankrupt, and many of whom will not and the market will have been wrong about.

Thanks soma2022 for such a valuable posts

If you still think rvnc is down 60 percent ytd mainly because of inflation and interest rate, I think we have to agree to disagree.

RVNC is not even in an highly inflation or rate sensitive sector

RVNC new 52 week low

As you said, RIVN is in a much more capital intensive market. Plus they have to scale up much bigger in order to compete on cost. Currently, their gross profit is still negative. So very different story

One of the offices I am friends with uses approximately 350 vials of Daxi a quarter. This practice was not part of the Daxi Prev program. The doctor does 95% of the toxin injections and there are 3 PA who injected the other 5%. The PAs have not converted patients to Daxi and are still using Botox. The doctor has converted 98% of the patients to Daxi and now has more availability on the schedule since the toxin patients are get more duration. The doctor is also making more profit per day/month using Daxi. Also, this office is now 100% RHA and no longer uses Juvederm.

It took the doctor about 3 months to master the Daxi injection technique. 98% of the patients stay with Daxi and do not go back to Botox.

On another topic, rumor is that both Daxi and RHA achieved their sales numbers in Q1.

I bought more earlier, but with a very tight stop loss.

Don't be ridiculous. I already posted about one, except they have billions in cash.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174304081

Call For Doctors/Med Spa owners on this Board to Share Daxxify Sales Data

As you all know, I am a long time injector of Daxxify since Prevu Dec 2022. I launched conservatively to a small portion of my practice, and since that time, Daxxify has taken over 80% of my own NT business (not including my nurse injectors). I used to be Botox only. This is the biggest revenue shift that I have seen in my practice in 20 years.

I am also seeing gradual adoption of Daxxify from many of my nurse injectors the past 3 quarters and we did over 6 figures of Daxxify purchases (over 400 vials) in Q1 2024. The march $75 rebates did help to get us to buy more Daxxify and to entice clients to try Daxxify. This represents over 500% growth over the Daxxify vials I used in Q12023. Although I am still the largest single injector of Daxxify in my organization, my nurse injectors, as a group, exceeded my total vials injected in Q4 2023 and have continued to grow their percentage of Daxxify used within my company.

I am seeing a 54% Daxxify adoption rate within my practice (7 of 13 nurses who trialed it in Q2/Q3 2023 are now ramping up sales in a meaningful way = 10 or more vials a month of Daxxify purchases). 25% are ramping up at a slower rate and 25% tried it and kind of gave up and couldn't quite figure it out or didn't want to take the time and effort to. This implies that roughly 50% of experienced nurse injectors will take 6 to 9 months to get comfortable with their injection outcomes and sales pitch before blowing it out, these nurse injectors tend to be our more authoritative and expert injectors - the type of nurse injectors that clients trust implicitly with 10 or more years of experience. These nurses are the heavy lifters in the NT industry that typically do 40 to 70 vials of NT each month. They likely account for 50% of the US NT market. They are my heavy hitters and largest profit centers. Moreover, the transition to Daxxify is making our organization more profitable with higher client satisfaction rates.

Emmanow, Edcoolidge, Boraborak38, others: would you be able to share some of your Daxxify purchase data for the board to gain some color on traction of Daxxify within your practice?

RVNC is much worse than most recently. Actually, find me another name that has 350mm cash on hand, that is down close to 40 percent MTD.

It’s clearly not just inflation or interest rate.

Perhaps the better question to Ms. Dtox would be: Do you feel the pricing change last fall and the change in messaging early this year and injectors getting more experience with the product have helped to course correct Daxi and do you feel that the worse is behind the Daxxify commercial launch?

Anyone selling? Buying?

The Board of Directors meeting is May 1st so there will probably be a preliminary earnings announcement before their May 5th Q1 date.

Also AbbVie will announce Botox sales tomorrow morning!

RVNC has cash to get them through the end of 2025.

CD Daxi sales will start May 9th…there is already a backlog of orders!

China approve any day!

I am convinced AbbVie has a fund which is shorting RVNC.

There are dozens or hundreds of comparisons just like this. RIVN makes fine products but they're unprofitable and their pathway to profitability is uncertain—not something people want to own in this interest rate environment. I don't own that stock but I've been looking for an entry point as I expect them to survive and they could easily be worth 10x in 10 years—but Rivian is far more likely than Revance to go bankrupt given the capital intensive nature of their business.

Trading for cash in bank now. Best product on market but terrible execution. No IR department to pitch the business. Crazy how they offered at 6.25 and a month later price is 3.25. They need to support the stock and Foley is silent until Q1 call which is when? Hope we get a PR…

You seem to be very naive and unaware about the movement of interest rates and inflation or that the exact same thing happening to RVNC is happening to many other loss-making companies right now. Some of these companies will go bankrupt but many won't. Market irrationality always lasts longer than you think but it doesn't last forever.

For sure, I would have never thought this will drop to this low.

Unless some fraud going on, I see this stock worth double digits at least.

They just raised 100mm

And they have 250mm cash on hand end of last year

They have CD and potential oversea milestones coming

But the sentiment is worse than awful

I think it’s buying time and have acted accordingly

The number of posters here buying this as it was falling day after day over the last year is startling.

I thought the 3.50-3.70 range was going to be bottom.

May look like 2.25-40 range now.

Looking for a point to jump in.

This feels different.

Down another 9% today, at $3.25. This is now a question of survival in my opinion.

"Crazy good deal"

Hope you are right. At some point, we have to be concerned that RVNC might not be able to survive (if at all) without ruinous dilution. Not sure when we reach that point.

The actual fight hasn’t started yet and David already lost 90 percent of his blood

Ms Dtox has been kindly and at personal risk trying to convey the situation from inside the company. For that, she's been accused of being an ABBV shill and 'full of it' among others. The stock is approaching $3. How about some gratitude and self reflection for a change?


The stock price is one thing and nobody who invested in RVNC is happy about it, myself included. Many investors have complained about management and I can't and don't argue with them about poor performance. When I asked Ms.Dtox to separate her negative views about management from the product Daxxify, her comment was laughable. I reflect all the time and continue to do so on all my investments. I am grateful for those who give real insights. I don't count Ms.Dtox among them as she comes here to whine about her losses and complain about cost cutting moves.

Did you mean Dysphagia?

Yes. Thanks for the correction.

Sometimes being David is just not good enough against Goliath…..

Just picked up some more shares

It’s crazy how a failed initial launch can cost 90 percent drop of the share price

30k shares used to be 1mm plus

Now just 100k

Crazy good deal

can we close green today? :)

Ms Dtox has been kindly and at personal risk trying to convey the situation from inside the company. For that, she's been accused of being an ABBV shill and 'full of it' among others. The stock is approaching $3. How about some gratitude and self reflection for a change?

There's nobody here who doesn't know what the trials showed.

Ptosis is CD?

Did you mean Dysphagia? Even one poster commented that injection technique and injection location in the muscle have changed over the years for CD injections.

.”Like other Neurotoxins individual results vary. Improved skin texture/tone is the big differentiator for me personally.”

Wow! Individual results vary!! Such a profound comment, which by the way can be applied to any drug, investment or even diet. It sure sounds familiar. Say, did you watch a lot of TV commercials before posting? Is that where you got the idea?

Ms.Dtox, sure sounds like you are still working for Allergan. It is very telling that you are unable or unwilling to acknowledge the bigger difference between Daxxify and Botox. That clinical trial data and real world data show that Daxxify's effects last close to twice as long based on as the median duration as Botox. Real world data is also coming back and indicating that Daxxify acts quicker than Botox. Add in that Ptosis was far less frequently with Daxxify in CD than with Botox and that is another win for Daxxify.

Favor, since you work at Revance, can you please tell IT/web design to remove Jessica from IR website. I dialed the number and a payroll associate picked up…

I stand by what I said on 3/31/24 .”Like other Neurotoxins individual results vary. Improved skin texture/tone is the big differentiator for me personally.”

When I worked for Allergan we used Lippe Taylor for some but not all ads and marketing materials. We did create and produce our own marketing materials and photo shoots and social media campaigns about 30 percent of the time with success.

Consumers remember in the moment what is right in front of them and this is cringeworthy.

Consumers remember what works for them or what they hear works for their friends and associates.

Sad, but true to all :(
Wonder what Erica’s budget is for 2024?

Enhanced and streamlined organizational structure:
— With the appointment of Erica Jordan as Chief Commercial Officer in the fourth quarter of 2023, the commercial organization was restructured to integrate and “streamline marketing, sales, commercial operations, professional part-nerships, strategy, data analytics and professional engagement functions”. The new structure is designed to support the company's strategic priorities by enhancing execution and performance while improving efficiencies.

Tried to ascertain 23’ Marketing/Advertising budget
( 10k), but as you know S,G & A* doesn’t get broken out by segment( doesn’t matter anyway, different model this year) last year: $297,732
($223,934–2022)

*SG&A expenses include most expenses related to running a business outside of
COGS. This includes salaries, rent, utilities, “advertising, marketing”, technology, and supplies not used in manufacturing.

Well, only couple weeks before Q1, so strap in , LFG !!! RVNC

Allergan has a great strategy here. They’ve got deep enough pockets to hire million dollar influencers (Kris Jenner promoting Botox gift cards) and they keep it more grassroots with casting calls. Revance is using C tier influencers because of budget constraints and the scripting/performance at that level can feel contrived.

Sounds like Allergan is scared and panicking. A superior product like Daxxify doesn't need to try and sway people with big advertising spending.

Ms.Dtox, for someone whose financial well-being is so tied up in RVNC you sure love to dis RVNC every chance you get. I don't think I ever read you say anything positive about RVNC or about Daxxify. Let's put aside your continuing attacks on RVNC management for a second. Do you at least think Daxxify is superior to Botox?

Allergan has always used and uses external marketing agencies for all of their ads and marketing materials! Botox has a product manager and assistant product manager…2 people. The assistant is the fill in for the product manager when they move to another job!

Allergan is most likely seeing a slow erosion of Botox sales and they are using influencers to try and slow the erosion! Remember, it cost $5 full load cost to produce a vial of Botox and AbbVie sells it for $656 per vial. Botox is the cash cow of aesthetics so AbbVie wants that profit at ALL costs!

It’s kind of embarrassing that a year ago Daxxify was presented as an elite allocated product to create FOMO demand and now Daxxify is being pitched by a minor mom influencer, it’s like we don’t even know who or what we are. Vogue and Time Magazine and the pendulum swing to this? Consumers remember in the moment what is right in front of them and this is cringeworthy. 😕

Allergan has a great strategy here. They’ve got deep enough pockets to hire million dollar influencers (Kris Jenner promoting Botox gift cards) and they keep it more grassroots with casting calls. Revance is using C tier influencers because of budget constraints and the scripting/performance at that level can feel contrived. There is no marketing team left, so everything we see in near future will be outside agency generated with the agency fee taking the biggest bite out of marketing budget. There is no effective strategy in place at this time.

Marketing heating up in this space! Revance can’t let guard down, should be an interesting 2nd half, 2024

https://www.fiercepharma.com/marketing/abbvie-starts-open-casting-call-next-faces-botox-ads-doubling-down-pitch-everyday-users

I agree… perhaps so we remember it. 🙃

I think that ad is pretty annoying actually.